Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: London Resources Stocks Plunge On Weak Commodities

Tue, 10th Mar 2015 16:58

LONDON (Alliance News) - UK stock indices were the heaviest hit in a global equities market sell-off Tuesday, with just four FTSE 100 stocks making gains, as a strong dollar and weak Chinese data weighed on commodities prices.

London's blue-chip index, which is heavily weighted with resources sector stocks, closed down 2.5% at 6,702.84, marking its worst one-day fall since October 15, while the FTSE 250 fell 1.4% to 16,922.49 and the AIM All-Share index declined 0.6% to 711.63.

European stocks were more resilient than London but still ended lower. The CAC 40 closed down 1.0% and the DAX 30 ended down 0.6%. Wall Street was also down sharply at the close of European equity markets, with the DJIA down 1.5%, the S&P 500 1.4% lower and the Nasdaq Composite down 1.5%.

The dollar continued to strengthen in the wake of strong US jobs data on Friday and the expectations of a summer rate hike by the US Federal Reserve. The Euro fell to a near 12-year low against the greenback at USD1.06963. The Euro was also weakened by the second day of the European Central Bank sovereign bond-purchasing and continued concerns about a possible Greek exit from the eurozone.

"The search for an end to the selling of EUR/USD continues, but with ECB QE in operation it looks like downward pressure will carry the euro ever closer to parity against the dollar. The slow disintegration of the recent Greece deal is not helping either, while most investors are prudently looking to boost dollar holdings at the expense of the euro," said Chris Beauchamp, senior market analyst at IG.

The dollar also rose to its highest level since July 2007 against the Japanese Yen to JPY122.023, but the pound has maintained above the psychological USD1.50.

The strength of the dollar weighed on commodities with oil, in particular, taking a hit. Brent fell to a low of USD56.31 a barrel, its lowest level since February 12, while West Texas Intermediate fell to a low of USD48.42 a barrel.

Oil-related stocks were amongst the worst-performing stocks in the FTSE 100, with Tullow Oil, down 6.2%, the worst performer, and BG Group, down 5.1%, the second-worst performer. Royal Dutch Shell 'B' ended down 4.8%, Weir Group down 3.3%, and BP down 4.0%.

In the FTSE 250, Cairn Energy closed down 7.3%, Premier Oil down 6.8% and SOCO International, down 5.4%.

The FTSE 350 oil and gas producers sector index closed down 4.8%, the worst-performing sector index, followed by the oil equipment services and distribution sector index, which dropped 3.9%.

The mining sector in London was also hit by weak Chinese producer prices. The National Bureau of Statistics said Chinese producer prices declined for the 36th consecutive month in February, weighing heavily on profit margins of companies. Industrial producer prices were down 4.8% from last year, which was bigger than a 4.3% fall seen a month ago. Economists had forecast prices to fall again by 4.3%. This was the biggest fall since October 2009. On a monthly basis, producer prices slid 0.7% after declining 1.1% in January.

Antofagasta ended down 4.3%, Glencore and Rio Tinto both ended down 1.7%, and BHP Billiton closed down 1.5%. In the FTSE 250, Lonmin closed as the worst performer, down 10.0%, while KAZ Minerals closed down 6.8% and Vedanta Resources down 6.9%.

The FTSE 350 mining sector index ended as the third-worst performing sector index, down 3.8%.

Allied Minds, up 7.7%, was one of the best performers in the FTSE 250. The company said it has formed BridgeSat Inc, which will build an optical connectivity system to improve the wireless transfer of data from satellites. BridgeSat co-invented the technology with the US federally-funded Aerospace Corp as part of a commercialisation collaboration.

Inchcape ended up 6.3% after the automotive retailer and distributer said its pretax profit declined due to a writedown on its Russian operations, but the company reported a rise in revenue and hiked its dividend. The company said its pretax profit for 2014 was GBP255.8 million, down from GBP266.1 million last year due to a GBP47.4 million goodwill impairment charge the company booked on its Russian operations. It said it was confident in the long-term potential of the Russian operations, but had reduced its near-term expectations due to the geopolitical uncertainties affecting the country. Still, stripping out exceptional costs, Inchcape's pretax profit rose to GBP303.2 million from GBP274.6 million.

Esure Group, down 9.1%, was the second-worst performer in the FTSE 250. The insurer reported a fall in pretax profit for 2014, blaming motor insurance market conditions and costs related to the acquisition of the remaining parts of GoCompare.

The company said its pretax profit for 2014 was GBP103.3 million, down 13% on the GBP118.4 million posted a year earlier due to the challenging conditions in the motor insurance market and due to costs related to the acquisition of the 50% of price comparison service GoCompare that it did not already own. Gross written premiums fell and the group cut its final dividend.

Optare, up 43%, was the biggest gainer in the AIM All-Share index. The bus maker got a GBP7.3 million order for its Solo single-decker buses from Stagecoach Group in the UK. Optare said it expects to deliver the Solos with Euro 6 emissions standards by the end of this year, although it didn't say how many. It said the order is in addition to five fully electric vehicles that it will deliver this month.

In the economic calendar Wednesday, Chinese retail sales are due at 0530 GMT, European Central Bank President Mario Draghi will be speaking in Frankfurt at 0800 GMT, UK industrial and manufacturing production for January is at 0930 GMT, and US MBA mortgage applications for the week ending March 6 is at 1100 GMT.

In the corporate calendar, drugmaker Hikma Pharmaceuticals, estate agency Foxtons Group, online gaming operator Bwin.party Digital Entertainment, and recruitment company Michael Page International will all be reporting full-year earnings. British home shopping retailer N Brown Group will be issuing a trading statement as will online-only fashion retailer Boohoo.com.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.